Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis

The serrated neoplasia pathway is an alternate route to colorectal cancer (CRC) development where <i>BRAF</i> <sup>V600E</sup> is the most common initiating genetic alteration. BRAF<sup>V600E</sup>-driven tumorigenesis requires gene expression changes mediated by activation of the ERK MAPK signaling pathway. However, the key effectors of this process are elusive. Here, we identify the ERK-regulated transcription factor Fosl1, one such effector. We show that Fosl1 is dispensable for the initiation of BRAF<sup>V600E</sup>-driven serrated neoplasia in mice but promotes progression of the disease by regulating the expression of genes involved in inflammation, immunity, cell cycle control, fetal-like programming, and gastric metaplasia. Notably, transgenic Fosl1 expression alone was sufficient to induce tumors with a <i>BRAF</i> <sup>V600E</sup>-like serrated morphology and transcriptional profile. These findings reveal a mechanism through which oncogenic BRAF-driven ERK signaling reprograms transcription to drive serrated neoplasia.

Authors

Institutions

Publication Details

Journal
iScience
Published
2025-10-28
DOI
https://doi.org/10.1016/j.isci.2025.113875
Citations
1
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis

Camilla M. Reehorst, Erwin F. Wagner, Faiza Basheer, Larry Croft et al.
1 citations
iScience
Protein Kinase Regulation and GTPase Signaling
0.81
article

Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis

Camilla M. Reehorst, Erwin F. Wagner, Faiza Basheer, Larry Croft, Eugene M. Tulchinsky, Amardeep S. Dhillon, Laura J. Jenkins, John M. Mariadason, Natalia Vukelic, Joshua Badshah, Fiona Chionh, Zakia Alam, Rebecca Nightingale, Troy Dumenil, Niall C. Tebbutt, Latifa Bakiri, Vicki Whitehall, Mark F. Richardson, Ian Y. Luk, Analia Lesmana, Cheng Liu
article en
1 citations

Abstract

The serrated neoplasia pathway is an alternate route to colorectal cancer (CRC) development where <i>BRAF</i> <sup>V600E</sup> is the most common initiating genetic alteration. BRAF<sup>V600E</sup>-driven tumorigenesis requires gene expression changes mediated by activation of the ERK MAPK signaling pathway. However, the key effectors of this process are elusive. Here, we identify the ERK-regulated transcription factor Fosl1, one such effector. We show that Fosl1 is dispensable for the initiation of BRAF<sup>V600E</sup>-driven serrated neoplasia in mice but promotes progression of the disease by regulating the expression of genes involved in inflammation, immunity, cell cycle control, fetal-like programming, and gastric metaplasia. Notably, transgenic Fosl1 expression alone was sufficient to induce tumors with a <i>BRAF</i> <sup>V600E</sup>-like serrated morphology and transcriptional profile. These findings reveal a mechanism through which oncogenic BRAF-driven ERK signaling reprograms transcription to drive serrated neoplasia.

iScienceVol. 28(11)
Deakin University (AU), The University of Melbourne (AU), La Trobe University (AU), QIMR Berghofer Medical Research Institute (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU), Mater Adult Hospital (AU), Nazarbayev University (KZ)
Openalex Percentile: Top 21%
Protein Kinase Regulation and GTPase Signaling
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.